Rodriguez Dania M, Madewell Zachary J, Torres Jomil M, Rivera Aidsa, Wong Joshua M, Santiago Gilberto A, Rivera-Amill Vanessa, Paz-Bailey Gabriela, Marzan-Rodriguez Melissa, Adams Laura E
MMWR Morb Mortal Wkly Rep. 2024 Dec 12;73(49):1112-1117. doi: 10.15585/mmwr.mm7349a1.
Dengue is a mosquitoborne viral illness that can cause acute febrile illness, severe disease, or death. Worldwide, the number of dengue cases is increasing. During the last dengue outbreaks in Puerto Rico throughout 2010-2013, dengue virus (DENV) serotype 1 (DENV-1) predominated, and the largest proportion of cases occurred among adolescents and young adults aged 10-19 years. Dengue case data from January 1, 2010-November 4, 2024, were obtained from the Puerto Rico Department of Health. Bivariate analyses were conducted to evaluate the distribution of cases by patient age, DENV serotype, and hospitalization status during three periods: 2010-2019, 2020-2022, and 2023-2024. During 2023-2024, the median age of dengue cases increased to 26 years (95% CI = 25-27 years) compared with that during 2020-2022 (17 years; 95% CI = 17-18 years) and 2010-2019 (19 years; 95% CI = 19-19 years). After >10 years of DENV-1 predominance, the proportions of DENV serotypes 2 (DENV-2) and 3 (DENV-3) increased significantly during 2023-2024, with DENV-3 replacing DENV-1 as the predominant serotype. In addition, the proportion of dengue patients who were hospitalized increased from 35.7% (2010-2019) to 53.5% (2023-2024). The current dengue outbreak in Puerto Rico marks a shift in serotype predominance to DENV-3 and increasing percentages of cases in older age groups (61.7% in adults aged ≥20 years), although a high proportion of cases still occur among adolescents aged 10-19 years (29.5%). The current dengue outbreak also has a higher rate of hospitalizations than those in previous years. Understanding the changing epidemiology of dengue is crucial to guiding public health strategies for dengue control, including clinical management, surveillance and health care system resilience, and public outreach and education.
登革热是一种由蚊子传播的病毒性疾病,可导致急性发热性疾病、严重疾病或死亡。在全球范围内,登革热病例数正在增加。在2010 - 2013年波多黎各的上一次登革热疫情期间,登革热病毒(DENV)血清型1(DENV - 1)占主导地位,且最大比例的病例发生在10 - 19岁的青少年和年轻成年人中。从波多黎各卫生部获取了2010年1月1日至2024年11月4日的登革热病例数据。进行了双变量分析,以评估三个时期(2010 - 2019年、2020 - 2022年和2023 - 2024年)按患者年龄、DENV血清型和住院状态划分的病例分布情况。在2023 - 2024年期间,登革热病例的中位年龄增至26岁(95%置信区间 = 25 - 27岁),而2020 - 2022年为17岁(95%置信区间 = 17 - 18岁),2010 - 2019年为19岁(95%置信区间 = 19 - 19岁)。在DENV - 1占主导地位超过10年后,2023 - 2024年期间DENV血清型2(DENV - 2)和3(DENV - 3)的比例显著增加,DENV - 3取代DENV - 1成为主要血清型。此外,登革热住院患者的比例从35.7%(2010 - 2019年)增至53.5%(2023 - 2024年)。波多黎各当前的登革热疫情标志着血清型优势转向DENV - 3,且老年人群体(≥20岁成年人中占61.7%)的病例百分比增加,尽管10 - 19岁青少年中仍有较高比例的病例(29.5%)。与前几年相比,当前的登革热疫情住院率也更高。了解登革热不断变化的流行病学对于指导登革热防控的公共卫生策略至关重要,包括临床管理、监测和医疗保健系统的恢复能力,以及公众宣传和教育。